The asymmetric total synthesis of (+)-cytotrienin a, an ansamycin-type anticancer drug.
Hayashi
Yujiro
Y
Department of Industrial Chemistry, Faculty of Engineering, Tokyo University of Science, Kagurazaka, Shinjuku-ku, Tokyo 162-8601, Japan. hayashi@ci.kagu.tus.ac.jp
Shoji
Mitsuru
M
Ishikawa
Hayato
H
Yamaguchi
Junichiro
J
Tamura
Tomohiro
T
Imai
Hiroki
H
Nishigaya
Yosuke
Y
Takabe
Kenichi
K
Kakeya
Hideaki
H
Osada
Hiroyuki
H
D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000737:chemistry*; D008968:Molecular Conformation; D017828:Rifabutin / Q000737:chemistry*; D012294:Rifamycins / Q000138:chemical synthesis* / Q000737:chemistry
D000970:Antineoplastic Agents; D012294:Rifamycins; C106761:cytotrienin A; D017828:Rifabutin